Vaccination during pregnancy with recombinant acellular pertussis vaccines containing genetically detoxified PT at lower content than acellular pertussis vaccines containing chemically detoxified PT results in efficient transplacental transfer of at least similar or higher quantity and quality anti-PT antibodies. The gene discussed is F2; the disease is pertussis.